Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

APRN Stock Alert: Blue Apron Surges on Buyout Offer

APRN stock has been a horrible stock to own since its 2017 IPO, but the worst is now over. It's Marc Lore's Wonder Group's problem now.

GME Stock Alert: Ryan Cohen Is Taking Over as GameStop CEO

Small investors still holding GME stock hope the man who led them into the name can turn the game retailer around.

Riding the Cloud Wave: Why Meta Platforms Is a Stock to Watch

Meta is taking an open source approach to its cloud development, just as it did a decade ago with the cloud itself. The difference is it has more control now, because it controls the license, and can change the terms.

AMC Price Prediction: Citi Claims AMC Entertainment Is Worth Less Than $5

CEO Adam Aron has saved AMC Entertainment from oblivion for now, but what AMC stock is worth is still up for debate.

DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer

The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.